Key result
APOE ϵ4 homozygosity linked to ~53% higher odds of extracranial carotid atherosclerotic plaque.
Why the study?
Carotid atherosclerotic plaque is an independent risk factor for stroke and APOE influences cholesterol levels, but the exact association between APOE and carotid plaque is uncertain.
Does APOE ε4 allele carrier status increase the risk of extracranial carotid atherosclerotic plaque in adults?
Meta-Analysis (n=36,245)
Does APOE ε4 allele carrier status increase the risk of extracranial carotid atherosclerotic plaque in adults?
The APOE ε4 allele, particularly in homozygous individuals, is significantly associated with the presence of extracranial carotid atherosclerotic plaque, suggesting a genetic susceptibility to atherosclerosis.
Answers are grounded in this paper and cite their sources.
APOE ε4 homozygosity may inform carotid plaque risk assessment; supports further genetic studies but should not yet change practice.
Introduction Carotid atherosclerotic plaque is an important independent risk factor for stroke. Apolipoprotein E (APOE) influences cholesterol levels and certain isoforms are associated with increased carotid atherosclerosis, though the exact association between APOE and carotid plaque is uncertain. The study aimed to evaluate the association between APOE and carotid plaque. Methods A systematic review was performed to retrieve all studies which examined the association between carotid plaque and APOE. This study was conducted in accordance with the PRISMA guidelines. Independent readers extracted the relevant data from each study including the type of imaging assessment, plaque definition, frequency of APOE E4 carrier status and type of genotyping. Meta-analyses with an assessment of study heterogeneity and publication bias were performed. Results were presented in a forest plot and summarized using a random-effects model. Results After screening 838 studies, 17 studies were included for systematic review. A meta-analysis of 5 published studies showed a significant association between ε 4 homozygosity and carotid plaque [odds ratio (OR), 1.53; 95% CI, 1.16, 2.02; p = .003]. Additionally, there was a significant association between patients possessing at least one ε 4 allele, heterozygotes or homozygotes, and carotid plaque (OR, 1.25; 95% CI, 1.03, 1.52; p = .03). Lastly, there was no association between ε 4 heterozygosity and carotid plaque (OR, 1.08; 95% CI, 0.93, 1.26; p = .30). Conclusion APOE ε 4 allele is significantly associated with extracranial carotid atherosclerotic plaque, especially for homozygous individuals.
No takes yet. Share an insight, caveat, or question.
Culleton et al. (2023) conducted a meta-analysis in Carotid atherosclerotic plaque (n=36,245). APOE ϵ4 homozygosity vs. Non-carriers or other APOE genotypes was evaluated on Presence of carotid plaque (OR 1.53, 95% CI 1.16-2.02, p=0.003). APOE ϵ4 homozygosity is significantly associated with the presence of extracranial carotid atherosclerotic plaque (OR 1.53).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: